HIV

Patients taking Truvada may still significantly reduce their risk of HIV infection even when they are not 100% adherent to their drug regimens, a new study revealed.

The Johnson & Johnson Patient Assistance Foundation, Inc (JJPAF) announced that it has started to use a new common patient assistance program application for the HIV medicines it offers, streamlining for patients in the United States the process of applying for HIV medicines from multiple patient assistance programs.

The generic marketplace remains dynamic and complicated, as patent expirations,interest in biosimilars, and international competition spur major changes.

Stribild, previously known as the Quad, has been approved by the FDA to treat HIV-1 infection in adults who are starting HIV treatment for the first time.

The FDA has expanded the indication of Merck's Isentress (raltegravir) to include pediatric patients.

The FDA approved an expanded indication for Isentress (raltegravir) to include the treatment of HIV-1 infection in children 2 years and older.

A new research and licensing partnership between the University of Pennsylvania and Novartis aims to develop more effective treatments for cancer by giving patients a disabled form of HIV.

Findings of a new study suggest women infected with HIV do not need more frequent Pap tests.

Treatment with antiretrovirals is now recommended for all adults with HIV infection, regardless of their CD4 count.

The initiative will provide greater insight into how the patient-pharmacist relationship can help improve retention in care, adherence and viral suppression outcomes.

The FDA approved Truvada for preexposure prophylaxis, making it the first agent ever to be approved for HIV prevention in uninfected adults.

The FDA today approved OraQuick In-Home HIV Test, the first over-the-counter HIV test that gives users results without having to send samples off to a lab.

Pharmacies and retail clinics are offering HIV testing in an effort to help reach the CDC's goal of testing every adolescent and adult in the country.

Pharmacies and retail clinics are offering HIV testing in an effort to help reach the CDC's goal of testing every adolescent and adult in the country.

The FDA will take an additional 3 months to review the drug application for Truvada as a preventive HIV treatment to account for updated safety materials submitted by Gilead.

An FDA advisory panel has recommended Truvada as a pre-exposure prophylaxis for people at risk of contracting HIV.

Access to food and shelter, rather than viral load count, is a better predictor of overall health among homeless HIV-infected men, according to a recent study.

New combination pills set to hit the market are expected to be more expensive than prior treatments.

The new guidelines offer detailed information on interactions between antiepileptic drugs and antiretroviral drugs.

Patients taking antiretroviral therapy can maximize their therapy when pharmacists educate them about their medication regimens.

Patients taking antiretroviral therapy can maximize their therapy when pharmacists educate them about their medication regimens.

The FDA sent out a "Drug Safety Communication" from their Division of Drug Information on February 9, 2012, listing the important new drug interactions between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitor drugs.